These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33234652)

  • 1. Cost-effectiveness analysis of population salt reduction interventions to prevent cardiovascular disease in Cameroon: mathematical modelling study.
    Aminde LN; Cobiac L; Veerman JL
    BMJ Open; 2020 Nov; 10(11):e041346. PubMed ID: 33234652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Impact and Cost-Effectiveness of Achieving the National Salt and Sugar Reduction Initiative Voluntary Sugar Reduction Targets in the United States: A Microsimulation Study.
    Shangguan S; Mozaffarian D; Sy S; Lee Y; Liu J; Wilde PE; Sharkey AL; Dowling EA; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
    Circulation; 2021 Oct; 144(17):1362-1376. PubMed ID: 34445886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Salt Reduction, Prevalence of Hypertension and Avoidable Burden of Stroke in Vietnam: Modelling the Health and Economic Impacts.
    Aminde LN; Phung HN; Phung D; Cobiac LJ; Veerman JL
    Front Public Health; 2021; 9():682975. PubMed ID: 34150712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Salt Substitute and Salt Supply Restriction in Eldercare Facilities: The DECIDE-Salt Cluster Randomized Clinical Trial.
    Lai X; Yuan Y; Wang H; Zhang R; Qiao Q; Feng X; Jin A; Li H; Li J; Si L; Gao P; Jan S; Fang H; Wu Y;
    JAMA Netw Open; 2024 Feb; 7(2):e2355564. PubMed ID: 38345818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study.
    Wang M; Moran AE; Liu J; Coxson PG; Penko J; Goldman L; Bibbins-Domingo K; Zhao D
    PLoS One; 2016; 11(2):e0146820. PubMed ID: 26840409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and cost-effectiveness of a school-based education program to reduce salt intake in children and their families in China.
    Li X; Jan S; Yan LL; Hayes A; Chu Y; Wang H; Feng X; Niu W; He FJ; Ma J; Han Y; MacGregor GA; Wu Y
    PLoS One; 2017; 12(9):e0183033. PubMed ID: 28902880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential impact of a modest reduction in salt intake on blood pressure, cardiovascular disease burden and premature mortality: a modelling study.
    Aminde LN; Cobiac LJ; Veerman JL
    Open Heart; 2019; 6(1):e000943. PubMed ID: 30997132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projected effect of dietary salt reductions on future cardiovascular disease.
    Bibbins-Domingo K; Chertow GM; Coxson PG; Moran A; Lightwood JM; Pletcher MJ; Goldman L
    N Engl J Med; 2010 Feb; 362(7):590-9. PubMed ID: 20089957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of salt reduction to prevent hypertension and CVD: a systematic review.
    Schorling E; Niebuhr D; Kroke A
    Public Health Nutr; 2017 Aug; 20(11):1993-2003. PubMed ID: 28487006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects.
    Nghiem N; Blakely T; Cobiac LJ; Cleghorn CL; Wilson N
    BMC Public Health; 2016 May; 16():423. PubMed ID: 27216490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries.
    Mason H; Shoaibi A; Ghandour R; O'Flaherty M; Capewell S; Khatib R; Jabr S; Unal B; Sözmen K; Arfa C; Aissi W; Ben Romdhane H; Fouad F; Al-Ali R; Husseini A;
    PLoS One; 2014; 9(1):e84445. PubMed ID: 24409297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study.
    Marklund M; Singh G; Greer R; Cudhea F; Matsushita K; Micha R; Brady T; Zhao D; Huang L; Tian M; Cobb L; Neal B; Appel LJ; Mozaffarian D; Wu JHY
    BMJ; 2020 Apr; 369():m824. PubMed ID: 32321724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health and economic impacts of eight different dietary salt reduction interventions.
    Nghiem N; Blakely T; Cobiac LJ; Pearson AL; Wilson N
    PLoS One; 2015; 10(4):e0123915. PubMed ID: 25910259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
    Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
    BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study.
    Barton P; Andronis L; Briggs A; McPherson K; Capewell S
    BMJ; 2011 Jul; 343():d4044. PubMed ID: 21798967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.
    Liu J; Mozaffarian D; Sy S; Lee Y; Wilde PE; Abrahams-Gessel S; Gaziano T; Micha R;
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006313. PubMed ID: 32493057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of a Household Salt Substitution Intervention: Findings From 20 995 Participants of the Salt Substitute and Stroke Study.
    Li KC; Huang L; Tian M; Di Tanna GL; Yu J; Zhang X; Yin X; Liu Y; Hao Z; Zhou B; Feng X; Li Z; Zhang J; Sun J; Zhang Y; Zhao Y; Zhang R; Yu Y; Li N; Yan LL; Labarthe DR; Elliott P; Wu Y; Neal B; Lung T; Si L
    Circulation; 2022 May; 145(20):1534-1541. PubMed ID: 35311346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis.
    Watkins DA; Olson ZD; Verguet S; Nugent RA; Jamison DT
    Health Policy Plan; 2016 Feb; 31(1):75-82. PubMed ID: 25841771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.